KR910007901A - 5-{2-[(2-아미노-2-옥소에틸)(메틸)아미노] 에틸}-2,3-디히드로-3-히드록시-2-(4-메톡시페닐)-1,5(5h)-벤조티아제핀-4-온 유도체. 그의 제조 및 치료에 있어서의 그의 이용 - Google Patents

5-{2-[(2-아미노-2-옥소에틸)(메틸)아미노] 에틸}-2,3-디히드로-3-히드록시-2-(4-메톡시페닐)-1,5(5h)-벤조티아제핀-4-온 유도체. 그의 제조 및 치료에 있어서의 그의 이용 Download PDF

Info

Publication number
KR910007901A
KR910007901A KR1019900016471A KR900016471A KR910007901A KR 910007901 A KR910007901 A KR 910007901A KR 1019900016471 A KR1019900016471 A KR 1019900016471A KR 900016471 A KR900016471 A KR 900016471A KR 910007901 A KR910007901 A KR 910007901A
Authority
KR
South Korea
Prior art keywords
amino
methyl
groups
benzothiazepin
oxoethyl
Prior art date
Application number
KR1019900016471A
Other languages
English (en)
Inventor
끌로드 뮐러 쟝
라살르 질베르
드니 꼴롬브
로셰드 알리스테어
Original Assignee
에. 뚜레 레메뜨르
신떼라보 소시에떼 아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에. 뚜레 레메뜨르, 신떼라보 소시에떼 아노님 filed Critical 에. 뚜레 레메뜨르
Publication of KR910007901A publication Critical patent/KR910007901A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

5-〔2-〔(2-아미노-2-옥소에틸)(메틸)아미노〕에틸〕-2,3-디히드로-3-히드록시-2-(4-메톡시페닐)-1.5(5H)-벤조티아제핀-4-온 유도체, 그의 제조 및 치료에 있어서의 그의 이용
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 일반식(I)에 해당하는 순수한 부분입체 이성질체 또는 그 혼합물 형태의 화합물 및 약리학적으로 허용되는 산과의 부가염.
    식중 R1은 수소원자 또는 C2-C4알카노일기를 나타내고, R2는 수소원자 또는 C2-C4알킬기를 나타내고, n은 0내지 3인 정수를 나타내고 R3은 할로겐 원자와 트리플루오로메틸, 메틸, C2-C4알콕시 또는 알킬티오, 니트로, 시아노, 카르바모일, 아세트아미도, 메탄술폰아미도, 메톡시카르보닐 또는 페닐카르보닐기로부터 선택된 1 내지 3개의 치환기를 가진 페닐기, 또는 피리딜 또는 이미다졸일기와 같은 방향족 헤테로시클릭기이다.
  2. 제1항에 따른 화합물의 제조방법에 있어서 일반식(Ⅵ)
    (식중 R1은 제1항에서 정의한 것과 같다.)
    의 벤조티아제피논과 일반식(Ⅱ)
    (식중 R2와 R3은 제1항에서 정의한 것과 같고 Y는 할로겐원자를 나타낸다)의 화합물이 반응하는 것을 특징으로 하는 방법.
  3. 제약학적 부형제와 함께 제1항과 제2항중의 하나에 따른 화합물을 함유하고 있는 것을 특징으로 하는 제약학적 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900016471A 1989-10-17 1990-10-16 5-{2-[(2-아미노-2-옥소에틸)(메틸)아미노] 에틸}-2,3-디히드로-3-히드록시-2-(4-메톡시페닐)-1,5(5h)-벤조티아제핀-4-온 유도체. 그의 제조 및 치료에 있어서의 그의 이용 KR910007901A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR89.13540 1989-10-17
FR8913540A FR2653122B1 (fr) 1989-10-17 1989-10-17 Derives de 5-[2-[[2-amino-2-oxoethyl]methylamino]ethyl]-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5(5h)-benzothiazepine-4-one, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
KR910007901A true KR910007901A (ko) 1991-05-30

Family

ID=9386468

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900016471A KR910007901A (ko) 1989-10-17 1990-10-16 5-{2-[(2-아미노-2-옥소에틸)(메틸)아미노] 에틸}-2,3-디히드로-3-히드록시-2-(4-메톡시페닐)-1,5(5h)-벤조티아제핀-4-온 유도체. 그의 제조 및 치료에 있어서의 그의 이용

Country Status (14)

Country Link
EP (1) EP0424214A1 (ko)
JP (1) JPH03133970A (ko)
KR (1) KR910007901A (ko)
AU (1) AU6479690A (ko)
CA (1) CA2027738A1 (ko)
FI (1) FI905089A0 (ko)
FR (1) FR2653122B1 (ko)
HU (1) HUT57754A (ko)
IE (1) IE903720A1 (ko)
IL (1) IL95931A0 (ko)
NO (1) NO904470L (ko)
NZ (1) NZ235717A (ko)
PT (1) PT95606A (ko)
ZA (1) ZA908267B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0702009B1 (en) * 1994-09-16 1998-07-01 Orion Corporation Fermion Method for the preparation of pharmaceutically active benzothiazepine derivatives
WO2005035505A2 (en) * 2003-09-30 2005-04-21 Artesian Therapeutics, Inc. Compounds with phosphodiesterase inhibiting and calcium channel blocking activities

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH538492A (de) * 1970-10-07 1973-06-30 Hoffmann La Roche Verfahren zur Herstellung von Benzodiazepin-Derivaten
FR2624117B1 (fr) * 1987-12-08 1991-02-22 Synthelabo Derives de hydroxy-3 (methoxy-4 phenyl)-2 (methylamino-2 ethyl)-5 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique
FR2630109B1 (fr) * 1988-04-19 1991-11-29 Synthelabo Derives de ((n-(amino-2 oxo-2 ethyl)methylamino)-2 ethyl)-5 hydroxy-3 (methoxy-4 phenyl)-2 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
IE903720A1 (en) 1991-04-24
FI905089A0 (fi) 1990-10-16
ZA908267B (en) 1991-08-28
JPH03133970A (ja) 1991-06-07
FR2653122A1 (fr) 1991-04-19
IL95931A0 (en) 1991-07-18
HU906466D0 (en) 1991-04-29
HUT57754A (en) 1991-12-30
NO904470L (no) 1991-04-18
CA2027738A1 (en) 1991-04-18
EP0424214A1 (fr) 1991-04-24
AU6479690A (en) 1991-07-11
NZ235717A (en) 1991-12-23
NO904470D0 (no) 1990-10-16
PT95606A (pt) 1991-09-13
FR2653122B1 (fr) 1994-04-15

Similar Documents

Publication Publication Date Title
DE69021472D1 (de) Pyrazolderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellung.
BR0111754A (pt) Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica
KR900001688A (ko) 벤조디아제핀 유도체
LU91196I2 (fr) Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO).
ES2137169T3 (es) Nuevos derivados de tiazolilbenzofurano, procedimientos para su preparacion y composicion farmaceutica que los contiene.
NO940737D0 (no) Antidepressive midler
KR910009672A (ko) 피리다진 유도체, 이의 제조방법 및 이것을 함유하는 약학 조성물
SE8503415L (sv) Nya isoindolinylalkylpiperaziner och farmaceutiska kompositioner innehallande desamma
KR900000343A (ko) 부텐 또는 프로펜 산 유도체
KR910014119A (ko) 항-고혈압 활성을 갖는 티아졸리딘 유도체 및 그의 치료용도
HU911992D0 (en) 2-(amino-alkyl)-5-(aryl-alkyl)-1,3-dioxanes, and process for the production of the medical preparations containing them
NO890440D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
KR910007901A (ko) 5-{2-[(2-아미노-2-옥소에틸)(메틸)아미노] 에틸}-2,3-디히드로-3-히드록시-2-(4-메톡시페닐)-1,5(5h)-벤조티아제핀-4-온 유도체. 그의 제조 및 치료에 있어서의 그의 이용
ATE13885T1 (de) Phenylpiperazinderivate von hetarylphenolen und hetarylanilinen, ihre herstellung und diese enthaltende therapeutische mittel.
KR910016734A (ko) 광학활성 알킬렌디옥시벤젠 유도체 및 치료에의 용도
KR870004006A (ko) 5-아릴-2,4-디알킬-3h-1,2,4-트리아졸-3-티온 및 이의 제조 방법
KR900009640A (ko) 벤족 사제핀 유도체
KR890016028A (ko) 5-{2-[n-(2-아미노-2-옥소에틸)메틸아미노]에틸}-3-히드록시-2-(4-메톡시페닐)-2,3-디히드로-1,5(5h)-벤조티아제핀-4-온 유도체, 그의 제법 및 치료에의 이용
KR950032146A (ko) 트리아졸 화합물 및 이의 제조방법 및 용도
FI862570A0 (fi) Nya aromatiska foereningar, deras ramstaellning och anvaendning.
KR900014339A (ko) 헤테로시클릭 화합물, 그의 제조방법, 이를 함유하는 제약 조성물 및 의약으로서의 용도
PT92377A (pt) Processo para a obtencao de composicoes farmaceuticas para o tratamento de estados depressivos, contendo derivados de cromano
IL83216A (en) 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them
FI874413A0 (fi) Foerfarande foer framstaellning av aralkyl-4h-1,2,4-triazolderivat.
KR890002143A (ko) 12-아미노-피리다지노[4',5':3.4]피롤로-[2.1-a]-이소퀴놀린의 심장보호 및 신경보호제로서의 용도

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid